Shionogi & Co. Ltd - Articles and news items

GlaxoSmithKline logo

Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio

Industry news, News / 29 October 2012 / GlaxoSmithKline

ViiV Healthcare Ltd and Shionogi & Co., Ltd., have entered into an agreement…

GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

Industry news, News / 2 April 2012 / GlaxoSmithKline

SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...